 Judith Shlay
Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sexually Transmitted Diseases | 11 | 2020 | 150 | 2.440 |
Why?
| | Text Messaging | 7 | 2022 | 149 | 2.370 |
Why?
| | School Health Services | 7 | 2015 | 233 | 2.240 |
Why?
| | Sexual Health | 6 | 2022 | 54 | 2.230 |
Why?
| | Immunization Programs | 6 | 2015 | 214 | 2.050 |
Why?
| | Pregnancy in Adolescence | 4 | 2017 | 81 | 1.560 |
Why?
| | Opioid-Related Disorders | 3 | 2022 | 484 | 1.250 |
Why?
| | Safety-net Providers | 2 | 2020 | 109 | 1.210 |
Why?
| | Sexual Behavior | 10 | 2022 | 483 | 1.040 |
Why?
| | Influenza Vaccines | 4 | 2015 | 532 | 1.030 |
Why?
| | Condoms | 5 | 2016 | 103 | 1.030 |
Why?
| | Reimbursement Mechanisms | 3 | 2015 | 84 | 0.960 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2014 | 94 | 0.840 |
Why?
| | Ambulatory Care Facilities | 5 | 2013 | 228 | 0.840 |
Why?
| | Pregnancy, Unwanted | 3 | 2009 | 14 | 0.760 |
Why?
| | Colorado | 15 | 2020 | 4421 | 0.750 |
Why?
| | Analgesics, Opioid | 4 | 2022 | 913 | 0.740 |
Why?
| | Body Composition | 7 | 2010 | 649 | 0.710 |
Why?
| | Attitude to Health | 2 | 2014 | 431 | 0.700 |
Why?
| | Family Planning Services | 2 | 2013 | 88 | 0.690 |
Why?
| | Contraception Behavior | 2 | 2016 | 97 | 0.670 |
Why?
| | Papillomavirus Infections | 6 | 2013 | 297 | 0.650 |
Why?
| | Contraception | 5 | 2022 | 153 | 0.640 |
Why?
| | HIV Infections | 12 | 2013 | 2720 | 0.600 |
Why?
| | Patient Participation | 2 | 2019 | 414 | 0.580 |
Why?
| | Influenza, Human | 2 | 2014 | 601 | 0.580 |
Why?
| | Anti-HIV Agents | 4 | 2009 | 754 | 0.570 |
Why?
| | Opiate Substitution Treatment | 1 | 2019 | 136 | 0.560 |
Why?
| | Parental Consent | 2 | 2014 | 25 | 0.560 |
Why?
| | Reverse Transcriptase Inhibitors | 2 | 2008 | 83 | 0.550 |
Why?
| | Sex Education | 1 | 2016 | 28 | 0.520 |
Why?
| | Adolescent | 25 | 2022 | 20393 | 0.520 |
Why?
| | Papanicolaou Test | 4 | 2013 | 42 | 0.500 |
Why?
| | Vaginal Smears | 4 | 2013 | 56 | 0.500 |
Why?
| | Parents | 2 | 2014 | 1309 | 0.490 |
Why?
| | Adolescent Health Services | 1 | 2015 | 76 | 0.460 |
Why?
| | Financing, Government | 1 | 2014 | 43 | 0.450 |
Why?
| | Minority Health | 1 | 2014 | 20 | 0.440 |
Why?
| | Social Values | 1 | 2014 | 34 | 0.440 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2014 | 100 | 0.420 |
Why?
| | Female | 45 | 2022 | 68776 | 0.420 |
Why?
| | Health Care Costs | 2 | 2014 | 367 | 0.400 |
Why?
| | Delivery of Health Care | 3 | 2022 | 894 | 0.400 |
Why?
| | Pregnancy | 14 | 2022 | 6402 | 0.390 |
Why?
| | Geographic Information Systems | 1 | 2011 | 42 | 0.370 |
Why?
| | Adult | 31 | 2020 | 35576 | 0.360 |
Why?
| | Tumor Virus Infections | 1 | 2011 | 46 | 0.360 |
Why?
| | Humans | 50 | 2022 | 129650 | 0.360 |
Why?
| | Health Promotion | 3 | 2022 | 719 | 0.360 |
Why?
| | Stavudine | 2 | 2008 | 8 | 0.360 |
Why?
| | Dideoxynucleosides | 2 | 2008 | 20 | 0.360 |
Why?
| | Lamivudine | 2 | 2008 | 61 | 0.350 |
Why?
| | Social Support | 1 | 2014 | 588 | 0.330 |
Why?
| | Male | 28 | 2020 | 63681 | 0.330 |
Why?
| | Subcutaneous Fat | 3 | 2010 | 74 | 0.320 |
Why?
| | Vaccines | 1 | 2014 | 398 | 0.310 |
Why?
| | Anti-Retroviral Agents | 4 | 2013 | 231 | 0.300 |
Why?
| | Public Health | 1 | 2013 | 484 | 0.300 |
Why?
| | Zidovudine | 1 | 2008 | 78 | 0.290 |
Why?
| | Vaccination | 3 | 2013 | 1348 | 0.290 |
Why?
| | Insurance, Health | 3 | 2015 | 267 | 0.280 |
Why?
| | Costs and Cost Analysis | 2 | 2020 | 201 | 0.270 |
Why?
| | HIV Protease Inhibitors | 1 | 2007 | 68 | 0.270 |
Why?
| | Health Status | 1 | 2011 | 755 | 0.260 |
Why?
| | Papillomavirus Vaccines | 3 | 2013 | 232 | 0.250 |
Why?
| | Middle Aged | 20 | 2019 | 31154 | 0.250 |
Why?
| | Patient Compliance | 1 | 2009 | 565 | 0.240 |
Why?
| | Primary Health Care | 2 | 2014 | 1680 | 0.240 |
Why?
| | Indians, North American | 1 | 2011 | 600 | 0.240 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 1098 | 0.230 |
Why?
| | Risk Assessment | 3 | 2013 | 3240 | 0.230 |
Why?
| | Antiretroviral Therapy, Highly Active | 5 | 2010 | 267 | 0.230 |
Why?
| | Community-Institutional Relations | 2 | 2015 | 95 | 0.220 |
Why?
| | Physicians | 1 | 2012 | 865 | 0.220 |
Why?
| | Diagnostic Errors | 1 | 2005 | 162 | 0.220 |
Why?
| | HIV-1 | 4 | 2011 | 836 | 0.210 |
Why?
| | Program Evaluation | 3 | 2016 | 875 | 0.200 |
Why?
| | Follow-Up Studies | 6 | 2017 | 4897 | 0.200 |
Why?
| | Pelvic Inflammatory Disease | 1 | 2022 | 10 | 0.190 |
Why?
| | United States | 9 | 2020 | 13903 | 0.190 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2013 | 1279 | 0.190 |
Why?
| | Intrauterine Devices | 1 | 2022 | 28 | 0.190 |
Why?
| | Reproductive Health | 1 | 2022 | 86 | 0.190 |
Why?
| | Long-Acting Reversible Contraception | 1 | 2022 | 32 | 0.190 |
Why?
| | Focus Groups | 2 | 2014 | 453 | 0.190 |
Why?
| | Human papillomavirus 16 | 2 | 2011 | 34 | 0.180 |
Why?
| | Electronic Health Records | 2 | 2022 | 975 | 0.180 |
Why?
| | Patient Acceptance of Health Care | 3 | 2014 | 759 | 0.180 |
Why?
| | Allied Health Personnel | 1 | 2020 | 41 | 0.160 |
Why?
| | Heroin | 1 | 2020 | 30 | 0.160 |
Why?
| | Cardiovascular Diseases | 1 | 2011 | 2004 | 0.160 |
Why?
| | Incidence | 4 | 2013 | 2644 | 0.160 |
Why?
| | Lipids | 3 | 2009 | 625 | 0.160 |
Why?
| | Prevalence | 5 | 2013 | 2564 | 0.150 |
Why?
| | Drug Prescriptions | 1 | 2020 | 248 | 0.150 |
Why?
| | Multivariate Analysis | 4 | 2009 | 1502 | 0.150 |
Why?
| | Inpatients | 1 | 2022 | 467 | 0.150 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2013 | 233 | 0.150 |
Why?
| | HIV-Associated Lipodystrophy Syndrome | 2 | 2010 | 12 | 0.140 |
Why?
| | Adipose Tissue | 4 | 2010 | 592 | 0.140 |
Why?
| | Cost-Benefit Analysis | 2 | 2013 | 569 | 0.130 |
Why?
| | Child | 5 | 2019 | 20883 | 0.130 |
Why?
| | Medicaid | 1 | 2020 | 433 | 0.130 |
Why?
| | Young Adult | 5 | 2019 | 12426 | 0.130 |
Why?
| | Reminder Systems | 1 | 2017 | 174 | 0.120 |
Why?
| | Drug Overdose | 1 | 2020 | 322 | 0.120 |
Why?
| | Organizational Case Studies | 1 | 2015 | 75 | 0.120 |
Why?
| | Machine Learning | 1 | 2020 | 443 | 0.120 |
Why?
| | Women's Health | 2 | 2009 | 365 | 0.110 |
Why?
| | Health Plan Implementation | 1 | 2015 | 137 | 0.110 |
Why?
| | Direct Service Costs | 1 | 2014 | 10 | 0.110 |
Why?
| | Immunization Schedule | 1 | 2015 | 197 | 0.110 |
Why?
| | Cervix Uteri | 2 | 2011 | 50 | 0.110 |
Why?
| | National Health Programs | 1 | 2013 | 17 | 0.110 |
Why?
| | Emergency Medical Services | 1 | 2020 | 522 | 0.110 |
Why?
| | AIDS Dementia Complex | 1 | 2013 | 51 | 0.110 |
Why?
| | Cross-Sectional Studies | 6 | 2013 | 5066 | 0.100 |
Why?
| | Sex Counseling | 2 | 2003 | 4 | 0.100 |
Why?
| | Mass Screening | 2 | 2013 | 1149 | 0.100 |
Why?
| | Research Design | 1 | 2019 | 1044 | 0.100 |
Why?
| | Models, Immunological | 1 | 2013 | 95 | 0.100 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1004 | 0.100 |
Why?
| | Health Services Needs and Demand | 1 | 2014 | 264 | 0.100 |
Why?
| | Time Factors | 4 | 2013 | 6556 | 0.100 |
Why?
| | Uterine Cervical Dysplasia | 2 | 2011 | 43 | 0.090 |
Why?
| | Medroxyprogesterone Acetate | 1 | 2011 | 35 | 0.090 |
Why?
| | Human papillomavirus 18 | 1 | 2011 | 15 | 0.090 |
Why?
| | Hospitalization | 1 | 2020 | 2070 | 0.090 |
Why?
| | Schools | 1 | 2014 | 439 | 0.090 |
Why?
| | Contraceptive Agents, Female | 1 | 2011 | 78 | 0.090 |
Why?
| | Self Efficacy | 1 | 2014 | 374 | 0.090 |
Why?
| | Urban Population | 2 | 2004 | 441 | 0.080 |
Why?
| | Protease Inhibitors | 1 | 2011 | 106 | 0.080 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 516 | 0.080 |
Why?
| | Long QT Syndrome | 1 | 2011 | 67 | 0.080 |
Why?
| | Health Education | 1 | 2013 | 334 | 0.080 |
Why?
| | Regression Analysis | 2 | 2009 | 993 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2013 | 504 | 0.080 |
Why?
| | Risk-Taking | 2 | 2002 | 347 | 0.080 |
Why?
| | Learning | 1 | 2013 | 403 | 0.080 |
Why?
| | Life Style | 1 | 2011 | 460 | 0.080 |
Why?
| | Pilot Projects | 1 | 2014 | 1587 | 0.080 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 1015 | 0.080 |
Why?
| | Cohort Studies | 4 | 2008 | 5420 | 0.070 |
Why?
| | Virology | 1 | 2008 | 23 | 0.070 |
Why?
| | Aged | 6 | 2011 | 22103 | 0.070 |
Why?
| | Odds Ratio | 1 | 2009 | 1023 | 0.070 |
Why?
| | Osteoporosis | 1 | 2009 | 232 | 0.060 |
Why?
| | Risk Factors | 5 | 2011 | 9765 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1501 | 0.060 |
Why?
| | Bone Density | 1 | 2009 | 471 | 0.060 |
Why?
| | Prospective Studies | 2 | 2009 | 7133 | 0.060 |
Why?
| | Didanosine | 1 | 2005 | 13 | 0.060 |
Why?
| | Socioeconomic Factors | 1 | 2009 | 1214 | 0.060 |
Why?
| | Genital Diseases, Female | 1 | 2005 | 27 | 0.060 |
Why?
| | Vaginosis, Bacterial | 1 | 2004 | 12 | 0.060 |
Why?
| | Urban Health Services | 1 | 2004 | 61 | 0.060 |
Why?
| | Abortion, Therapeutic | 1 | 2003 | 4 | 0.050 |
Why?
| | Spermatocidal Agents | 1 | 2003 | 7 | 0.050 |
Why?
| | CD4 Lymphocyte Count | 3 | 2010 | 266 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2015 | 1368 | 0.050 |
Why?
| | Pregnancy Rate | 1 | 2003 | 61 | 0.050 |
Why?
| | Catheters, Indwelling | 1 | 2003 | 80 | 0.050 |
Why?
| | Hysterectomy | 1 | 2003 | 118 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2009 | 2717 | 0.050 |
Why?
| | Community Health Centers | 1 | 2002 | 57 | 0.050 |
Why?
| | Program Development | 2 | 2015 | 357 | 0.050 |
Why?
| | Postoperative Care | 1 | 2003 | 241 | 0.050 |
Why?
| | Contraceptive Agents | 1 | 2022 | 65 | 0.050 |
Why?
| | Risk | 1 | 2004 | 854 | 0.050 |
Why?
| | Blood Glucose | 2 | 2009 | 2097 | 0.040 |
Why?
| | Insulin Resistance | 2 | 2009 | 1165 | 0.040 |
Why?
| | Forecasting | 1 | 2002 | 359 | 0.040 |
Why?
| | Papillomaviridae | 2 | 2013 | 114 | 0.040 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2004 | 367 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1838 | 0.040 |
Why?
| | Counseling | 1 | 2003 | 385 | 0.040 |
Why?
| | Child, Preschool | 1 | 2014 | 10517 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2002 | 1201 | 0.040 |
Why?
| | Logistic Models | 1 | 2004 | 1988 | 0.040 |
Why?
| | Absorptiometry, Photon | 2 | 2010 | 248 | 0.040 |
Why?
| | Insulin | 2 | 2009 | 2326 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2003 | 732 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2022 | 14518 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2002 | 1952 | 0.030 |
Why?
| | Viral Load | 2 | 2011 | 448 | 0.030 |
Why?
| | Electric Impedance | 2 | 2007 | 101 | 0.030 |
Why?
| | Automation | 1 | 2015 | 82 | 0.030 |
Why?
| | Motivation | 1 | 2020 | 546 | 0.030 |
Why?
| | Cell Phone | 1 | 2015 | 70 | 0.030 |
Why?
| | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2013 | 15 | 0.030 |
Why?
| | Epidemiological Monitoring | 1 | 2013 | 50 | 0.030 |
Why?
| | Data Collection | 1 | 2015 | 650 | 0.020 |
Why?
| | Coitus | 1 | 2011 | 25 | 0.020 |
Why?
| | Sentinel Surveillance | 1 | 2011 | 41 | 0.020 |
Why?
| | Sex Factors | 2 | 2008 | 1968 | 0.020 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2011 | 58 | 0.020 |
Why?
| | Needs Assessment | 1 | 2013 | 360 | 0.020 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2010 | 13 | 0.020 |
Why?
| | Radionuclide Imaging | 1 | 2010 | 123 | 0.020 |
Why?
| | Sexual Partners | 1 | 2011 | 185 | 0.020 |
Why?
| | Health Behavior | 1 | 2015 | 741 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 5762 | 0.020 |
Why?
| | Hip Joint | 1 | 2009 | 158 | 0.020 |
Why?
| | Adolescent Behavior | 1 | 2013 | 506 | 0.020 |
Why?
| | Lumbar Vertebrae | 1 | 2009 | 231 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 769 | 0.020 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2008 | 132 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2011 | 2012 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2008 | 198 | 0.020 |
Why?
| | Liver Diseases | 1 | 2008 | 290 | 0.010 |
Why?
| | Treatment Outcome | 2 | 2011 | 10230 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1038 | 0.010 |
Why?
| | Anthropometry | 1 | 2005 | 204 | 0.010 |
Why?
| | Prognosis | 1 | 2013 | 3794 | 0.010 |
Why?
| | Metronidazole | 1 | 2004 | 20 | 0.010 |
Why?
| | Verbal Behavior | 1 | 2004 | 46 | 0.010 |
Why?
| | Fractures, Bone | 1 | 2009 | 392 | 0.010 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2004 | 170 | 0.010 |
Why?
| | Device Removal | 1 | 2003 | 136 | 0.010 |
Why?
| | RNA, Viral | 1 | 2005 | 619 | 0.010 |
Why?
| | Anti-Infective Agents | 1 | 2004 | 248 | 0.010 |
Why?
| | Recurrence | 1 | 2004 | 1007 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 5406 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2004 | 718 | 0.010 |
Why?
| | Age Factors | 1 | 2007 | 3144 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1501 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2535 | 0.010 |
Why?
| | Body Mass Index | 1 | 2007 | 2273 | 0.010 |
Why?
| | Pain | 1 | 2003 | 789 | 0.010 |
Why?
|
|
Shlay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|